Lacrimal Stent and Intubation Sets Market Size and Forecasts (2021 - 2031), Global and Regional Share, Trends, and Growth Opportunity Analysis

MARKET OVERVIEW

Lacrimal stents are small diameter tubes placed within the nasolacrimal system to maintain patency. In most cases, the tubes are typically composed of silicone or similar semi-rigid yet flexible material with an open central lumen. Intubation of the nasolacrimal system is generally done temporarily, with stents remaining in place for several months. In rare instances, however, intubation may be long-term. Nasolacrimal tubes are used majorly in obstruction or laceration of one or more parts of the tear drainage system. Lacrimal intubation has become a general surgical procedure for congenital nasolacrimal duct obstruction that does not respond to conservative medical treatment or failed probing. Several Lacrimal Duct Stent Tube devices are available in the Lacrimal Duct Stent Tube market, such as monocanalicular lacrimal duct stent tube, bicanalicular lacrimal duct stent tube.

MARKET SCOPE

The "Global Lacrimal Stent and Intubation Sets Market Analysis to 2031" is a specialized and in-depth study of the medical devices industry with a special focus on the global market trend analysis. The report aims to provide an overview of the Lacrimal stent and intubation sets market with detailed market segmentation by type, end use, and geography. The report provides key statistics on the market status of the leading Lacrimal stent and intubation sets market players and offers key trends and opportunities in the market.

MARKET SEGMENTATION

•  Based on type, the global Lacrimal stent and intubation sets market is segmented into monocanalicular stents, bicanalicular stents.
  
•  On the basis of end use, the market is segmented into hospitals, clinics, others.
  

MARKET DYNAMICS

Drivers

•  Rise in the incidences of nasolacrimal duct obstruction.
  
•  Rise in the demand for treatments with minimal invasions.
  
•  Rising awareness amongst the people about various types of surgeries regarding nasolacrimal duct obstruction
  

Restraints

•  The high cost of treatment device, increasing risk of complications is the major restraining factor for this market.
  

REGIONAL FRAMEWORK

The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides an overview and forecast of the global market based on various segments. It also provides market size and forecast estimates from the year 2021 to 2031 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), the Middle East and Africa (MEA), and South America. The Lacrimal stent and intubation sets market by each region is later sub-segmented by respective countries and segments. The report covers the analysis and forecast of 18 countries globally along with the current trend and opportunities prevailing in the region.

The report analyzes factors affecting the market from both demand and supply side and further evaluates market dynamics affecting the marketduring the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA, and South America after evaluating political, economic, social and technological factors affecting the Lacrimal stent and intubation sets market in these regions.

IMPACT OF COVID-19 ON LACRIMAL STENT AND INTUBATION SETS MARKET

COVID-19 first began in Wuhan (China) during December 2019 and since then it has spread at a fast pace across the globe. The US, India, Brazil, Russia, France, the UK, Turkey, Italy, and Spain are some of the worst affected countries in terms confirmed cases and reported deaths. The COVID-19 has been affecting economies and industries in various countries due to lockdowns, travel bans, and business shutdowns. Shutdown of various plants and factories has affected the global supply chains and negatively impacted the manufacturing, delivery schedules, and sales of products in global market. Few companies have already announced possible delays in product deliveries and slump in future sales of their products. In addition to this, the global travel bans imposed by countries in Europe, Asia-Pacific, and North America are affecting the business collaborations and partnerships opportunities.

MARKET PLAYERS

The report covers key developments in the Lacrimal stent and intubation sets market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies activities witnessed in the marketwere acquisitions, and partnership & collaborations. These activities have paved way for the expansion of business and customer base of market players. The market payers from Lacrimal stent and intubation sets market are anticipated to lucrative growth opportunities in the future with the rising demand for Lacrimal stent and intubation sets in the global market.

The report also includes the profiles of key companies along with their SWOT analysis and market strategies in the Lacrimal stent and intubation sets market. In addition, the report focuses on leading industry players with information such as company profiles, components, and services offered, financial information of the last 3 years, the key development in the past five years.

•  Aurolab
  
•  Bess Medizintechnik GmbH
  
•  FCI Ophthalmics
  
•  Gunther Weiss Scientific Glass
  
•  Kaneka Pharma America LLC
  
•  Beaver-Visitec International
  
•  FCI Ophthalmics
  
•  Fruida
  
•  Sinopsys Surgical
  
•  Cook Medical
  

The Insight Partner's dediLacrimal stent and intubation setsed research and analysis team consist of experienced professionals with advanced statistical expertise and offer various customization options in the existing study.

Lacrimal Stent and Intubation Sets Report Scope